Pharmadil
ActiveSummary
The computed 12-month bankruptcy probability of Pharmadil is 7.5% (elevated). For Pharmadil, one filing cycle of the annual accounts is missing. The 2024 annual accounts show negative equity (-€88,047) and a net result of -€69,128. Equity is shrinking by about 62% per year across the filed financial years. Its solvency ranks better than 8% of 9,658 sector peers (NACE 47, financial year 2024). The company has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Owners and capital
Owners
1 ownerChain of control
- MSP INVEST
- Pharmadil
Highest known parent: MSP INVEST. The sources do not say who stands above it.
Owners 1
- MSP INVESTparent99.9%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.